Bell Ceremonies

SpyGlass Pharma Rings the Nasdaq Stock Market Opening Bell

Published

SpyGlass Pharma, Inc. (Nasdaq: SGP), a late-stage biopharmaceutical company dedicated to transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Patrick Mooney, Chief Executive Officer rings the Opening Bell.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now